title: Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration.
abstract: Age-related macular degeneration (AMD) is a sight threating retinal eye disease that affects millions of aging individuals world-wide. Choroid-retinal pigment epithelium (RPE)-neuroretina axis in the posterior compartment of the eye is the primary site of AMD pathology. There are compelling evidence to indicate association of vascular endothelial growth factors (VEGF) to AMD. Here, we report the inhibitory actions of resveratrol (RSV) on inflammatory cytokine, TGF-β and hypoxia induced VEGF secretion by human retinal pigment epithelial cells (HRPE). HRPE cultures prepared from aged human donor eyes were used for the studies in this report. HRPE secreted both VEGF-A and VEGF-C in small quantities constitutively. Stimulation with a mixture of inflammatory cytokines (IFN-γ, TNF-α, IL-1β), significantly increased the secretion of both VEGF-A and VEGF-C. RSV, in a dose dependent (10-50 uM) manner, suppressed VEGF-A and VEGF-C secretion induced by inflammatory cytokines significantly. RT-PCR analysis indicated that effects of RSV on VEGF secretion were possibly due to decreased mRNA levels. TGF-β and cobalt chloride (hypoxia mimic) also upregulated HRPE cell production of VEGF-A, and this was inhibited by RSV. In contrast, RSV had no effect on anti-angiogenic molecules, endostatin and pigment epithelial derived factor secretion. Studies using an in vitro scratch assay revealed that wound closure was also inhibited by RSV. These results demonstrate that RSV can suppress VEGF secretion induced by inflammatory cytokines, TGF-β and hypoxia. Under pathological conditions, over expression of VEGF is known to worsen AMD. Therefore, RSV may be useful as nutraceutical in controlling pathological choroidal neovascularization processes in AMD.
authors.affiliation: Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
authors.forename: Chandrasekharam N
authors.initials: CN
authors.lastname: Nagineni
authors.affiliation: Departments of Medical Laboratory, Imaging and Radiological Sciences, and Biochemistry and Molecular Biology, Georgia Regents University, Augusta, Georgia, USA.
authors.forename: Raghavan
authors.initials: R
authors.lastname: Raju
authors.affiliation: School of Public Policy, University of Maryland, College Park, Maryland, USA.
authors.forename: Krishnasai K
authors.initials: KK
authors.lastname: Nagineni
authors.affiliation: Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
authors.forename: Vijay K
authors.initials: VK
authors.lastname: Kommineni
authors.affiliation: Laboratory of Retinal Cell and Molecular Biology, National Eye institute, NIH, Bethesda, Maryland.
authors.forename: Aswini
authors.initials: A
authors.lastname: Cherukuri
authors.affiliation: Laboratory of Retinal Cell and Molecular Biology, National Eye institute, NIH, Bethesda, Maryland.
authors.forename: R Krishnan
authors.initials: RK
authors.lastname: Kutty
authors.affiliation: Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
authors.forename: John J
authors.initials: JJ
authors.lastname: Hooks
authors.affiliation: Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
authors.forename: Barbara
authors.initials: B
authors.lastname: Detrick
keywords: Age-related macular degeneration; Cytokines; Resveratrol; Retina; Retinal pigment epithelium; SIRT1; VEGF
references.citation: Annu Rev Genomics Hum Genet. 2009;10:19-43
references.pmid: 19405847
references.citation: Arch Biochem Biophys. 2010 Sep 1;501(1):79-90
references.pmid: 20450879
references.citation: J Cell Physiol. 2003 Dec;197(3):453-62
references.pmid: 14566975
references.citation: Prog Retin Eye Res. 2008 Jul;27(4):331-71
references.pmid: 18653375
references.citation: Altern Med Rev. 2010 Sep;15(3):245-63
references.pmid: 21155626
references.citation: Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3612-24
references.pmid: 16877436
references.citation: Mol Vis. 2002 Apr 21;8:119-26
references.pmid: 11979237
references.citation: Nat Rev Immunol. 2013 Jun;13(6):438-51
references.pmid: 23702979
references.citation: Nutrients. 2013 Jun 04;5(6):1989-2005
references.pmid: 23736827
references.citation: Mol Med. 2012 Mar 27;18:209-14
references.pmid: 22113495
references.citation: J Ocul Pharmacol Ther. 2011 Aug;27(4):315-21
references.pmid: 21663493
references.citation: Ann N Y Acad Sci. 2011 Jan;1215:48-59
references.pmid: 21261641
references.citation: Arch Ophthalmol. 2009 Dec;127(12):1678-9
references.pmid: 20008727
references.citation: Arch Ophthalmol. 2011 Jan;129(1):75-80
references.pmid: 21220632
references.citation: FASEB J. 2001 Aug;15(10):1798-800
references.pmid: 11481234
references.citation: Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3178-88
references.pmid: 7519180
references.citation: Mol Aspects Med. 2012 Aug;33(4):318-75
references.pmid: 22503690
references.citation: Nature. 2005 Sep 22;437(7058):497-504
references.pmid: 16177780
references.citation: Nature. 2009 Jul 30;460(7255):587-91
references.pmid: 19641587
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):493-506
references.pmid: 16732220
references.citation: Br J Ophthalmol. 1997 Feb;81(2):154-62
references.pmid: 9059252
references.citation: J Ophthalmol. 2012;2012:786870
references.pmid: 22523653
references.citation: Arch Ophthalmol. 2004 Apr;122(4):598-614
references.pmid: 15078679
references.citation: J Cell Physiol. 2007 Jan;210(1):192-200
references.pmid: 17013806
references.citation: Surv Ophthalmol. 1987 Mar-Apr;31(5):291-306
references.pmid: 3299827
references.citation: Food Chem Toxicol. 2009 Sep;47(9):2170-82
references.pmid: 19505523
references.citation: Am J Pathol. 2005 Nov;167(5):1451-9
references.pmid: 16251428
references.citation: J Cell Physiol. 2012 Jan;227(1):116-26
references.pmid: 21374591
references.citation: Antioxid Redox Signal. 2009 Nov;11(11):2851-97
references.pmid: 19432534
references.citation: Arch Ophthalmol. 2004 Apr;122(4):564-72
references.pmid: 15078675
references.citation: J Biol Chem. 1997 Oct 3;272(40):25176-83
references.pmid: 9312130
references.citation: J Mol Med (Berl). 2013 Mar;91(3):311-21
references.pmid: 23329331
references.citation: Nutrients. 2013 Jul 02;5(7):2405-56
references.pmid: 23820727
references.citation: EMBO J. 1996 Apr 1;15(7):1751
references.pmid: 8612600
references.citation: Invest Ophthalmol Vis Sci. 1996 Apr;37(5):855-68
references.pmid: 8603870
references.citation: Aging (Albany NY). 2009 Dec 27;2(1):28-42
references.pmid: 20228934
references.citation: Prog Retin Eye Res. 2001 Nov;20(6):705-32
references.pmid: 11587915
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10794-9
references.pmid: 12960381
references.citation: J Cell Physiol. 2005 Apr;203(1):35-43
references.pmid: 15368539
references.citation: Prog Retin Eye Res. 2003 Nov;22(6):721-48
references.pmid: 14575722
references.citation: Am J Ophthalmol. 2007 Oct;144(4):618-26
references.pmid: 17698021
references.citation: Nat Med. 2003 Jun;9(6):669-76
references.pmid: 12778165
references.citation: Invest Ophthalmol Vis Sci. 2011 Nov 04;52(12):8614-20
references.pmid: 21960553
references.citation: Neuron. 2012 Jul 12;75(1):26-39
references.pmid: 22794258
references.citation: Exp Eye Res. 2006 Jan;82(1):99-110
references.pmid: 16019000
references.citation: Am J Ophthalmol. 2002 Sep;134(3):411-31
references.pmid: 12208254
references.citation: J Immunol. 2008 Mar 15;180(6):3789-96
references.pmid: 18322185
references.citation: Am J Pathol. 2010 Jul;177(1):481-92
references.pmid: 20472894
references.citation: Biochem Biophys Res Commun. 2010 Jan 1;391(1):287-92
references.pmid: 19913506
references.citation: Mol Aspects Med. 2012 Aug;33(4):295-317
references.pmid: 22542780
references.citation: J Biol Chem. 1991 Jun 25;266(18):11947-54
references.pmid: 1711045
references.citation: Prog Retin Eye Res. 2001 May;20(3):385-414
references.pmid: 11286898
references.citation: Prog Retin Eye Res. 2007 Jan;26(1):1-37
references.pmid: 17074526
references.citation: Retina. 1994;14(2):130-42
references.pmid: 8036323
references.citation: Mol Vis. 2006 Dec 22;12:1649-59
references.pmid: 17200665
references.citation: Chem Biol Interact. 2005 Jan 15;151(2):143-9
references.pmid: 15698585
references.citation: Physiol Rev. 2005 Jul;85(3):845-81
references.pmid: 15987797
references.citation: PLoS One. 2011;6(9):e23148
references.pmid: 21912637
references.citation: Int J Inflam. 2013;2013:348092
references.pmid: 23762772
references.citation: J Cell Sci Suppl. 1993;17:189-95
references.pmid: 8144697
references.citation: Trends Mol Med. 2007 Aug;13(8):345-52
references.pmid: 17644433
references.citation: Clin Diagn Lab Immunol. 1994 Sep;1(5):569-77
references.pmid: 8556503
references.citation: Cell Cycle. 2008 Apr 15;7(8):1020-35
references.pmid: 18414053
references.citation: Surv Ophthalmol. 2006 Mar-Apr;51(2):137-52
references.pmid: 16500214